Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi

Blood Adv. 2018 Nov 30;2(Suppl 1):30-32. doi: 10.1182/bloodadvances.2018GS110347.

Tisungane Mvalo^{1

2}, Hillary Topazian^{1

3}, Portia Kamthunzi^{1

4}, Jane Chen^{1

3}, Isobel Kambalame¹, Pilirani Mafunga¹, Noel Mumba¹, Msandeni Chiume-Chiphaliwali⁵, Khadija Paseli⁶, Nigel Key⁷, Satish Gopal^{1

4}, Irving Hoffman^{1

4}, Ken Ataga⁷, Kate Westmoreland^{1

8}

¹ University of North Carolina Project-Malawi, Lilongwe, Malawi.
² Department of Pediatrics.
³ Department of Epidemiology, and.
⁴ Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC.
⁵ Department of Pediatrics, and.
⁶ Ministry of Health, Kamuzu Central Hospital, Lilongwe, Malawi; and.
⁷ Division of Hematology, and.
⁸ Division of Pediatric Hematology-Oncology, University of North Carolina, Chapel Hill, NC.

No abstract available

Publication types